KR20110015449A - 아르포르모테롤의 합성방법 - Google Patents

아르포르모테롤의 합성방법 Download PDF

Info

Publication number
KR20110015449A
KR20110015449A KR1020107029606A KR20107029606A KR20110015449A KR 20110015449 A KR20110015449 A KR 20110015449A KR 1020107029606 A KR1020107029606 A KR 1020107029606A KR 20107029606 A KR20107029606 A KR 20107029606A KR 20110015449 A KR20110015449 A KR 20110015449A
Authority
KR
South Korea
Prior art keywords
compound
formula
acid
salt
diastereomer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
KR1020107029606A
Other languages
English (en)
Korean (ko)
Inventor
바만 바이쉬알리 할다바네카르
만게쉬 프라브후
다르마라즈 라마찬드라 라오
라젠드라 나라얀라오 칸칸
Original Assignee
시플라 리미티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 시플라 리미티드 filed Critical 시플라 리미티드
Publication of KR20110015449A publication Critical patent/KR20110015449A/ko
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00—Preparation of carboxylic acid amides
    • C07C231/10—Preparation of carboxylic acid amides from compounds not provided for in groups C07C231/02 - C07C231/08
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C213/00—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C213/00—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
    • C07C213/08—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton by reactions not involving the formation of amino groups, hydroxy groups or etherified or esterified hydroxy groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C213/00—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
    • C07C213/10—Separation; Purification; Stabilisation; Use of additives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/54—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C217/56—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by singly-bound oxygen atoms
    • C07C217/60—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by singly-bound oxygen atoms linked by carbon chains having two carbon atoms between the amino groups and the six-membered aromatic ring or the condensed ring system containing that ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/78—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton
    • C07C217/80—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of non-condensed six-membered aromatic rings
    • C07C217/82—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of non-condensed six-membered aromatic rings of the same non-condensed six-membered aromatic ring
    • C07C217/84—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of non-condensed six-membered aromatic rings of the same non-condensed six-membered aromatic ring the oxygen atom of at least one of the etherified hydroxy groups being further bound to an acyclic carbon atom
    • C07C217/86—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of non-condensed six-membered aromatic rings of the same non-condensed six-membered aromatic ring the oxygen atom of at least one of the etherified hydroxy groups being further bound to an acyclic carbon atom to an acyclic carbon atom of a hydrocarbon radical containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00—Preparation of carboxylic acid amides
    • C07C231/02—Preparation of carboxylic acid amides from carboxylic acids or from esters, anhydrides, or halides thereof by reaction with ammonia or amines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/34—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups
    • C07C233/42—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring
    • C07C233/43—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring having the carbon atom of the carboxamide group bound to a hydrogen atom or to a carbon atom of a saturated carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07—Optical isomers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
KR1020107029606A 2008-06-02 2009-06-02 아르포르모테롤의 합성방법 Abandoned KR20110015449A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN1172/MUM/2008 2008-06-02
IN1172MU2008 2008-06-02

Publications (1)

Publication Number Publication Date
KR20110015449A true KR20110015449A (ko) 2011-02-15

Family

ID=40839516

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020107029606A Abandoned KR20110015449A (ko) 2008-06-02 2009-06-02 아르포르모테롤의 합성방법

Country Status (10)

Country Link
US (2) US9029421B2 (https=)
EP (1) EP2285770B1 (https=)
JP (2) JP2011523658A (https=)
KR (1) KR20110015449A (https=)
AU (1) AU2009253877B2 (https=)
CA (1) CA2724882A1 (https=)
ES (1) ES2539947T3 (https=)
NZ (1) NZ589497A (https=)
WO (1) WO2009147383A1 (https=)
ZA (1) ZA201008222B (https=)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2539947T3 (es) 2008-06-02 2015-07-07 Cipla Limited Procedimiento para la síntesis de arformoterol
WO2010128355A2 (en) * 2008-12-26 2010-11-11 Actavis Group Ptc Ehf Improved processes for preparing substantially pure arformoterol and its intermediates
EP2348013A1 (en) 2010-01-25 2011-07-27 Inke, S.A. Process for preparation of intermediates of arformoterol
MX347218B (es) 2010-04-12 2017-04-20 Supernus Pharmaceuticals Inc Metodos para producir sales de viloxazina y polimorfos novedosos de las mismas.
RU2678992C2 (ru) * 2012-04-11 2019-02-05 Сипла Лимитед Фармацевтическая композиция, содержащая арформотерол и флутиказона фуроат
CN103664677A (zh) * 2012-09-05 2014-03-26 中山大学 一种(r,r)-福莫特罗酒石酸盐的不对称合成方法
CN106518690A (zh) * 2016-09-21 2017-03-22 北京万全德众医药生物技术有限公司 酒石酸阿福特罗重要中间体的一种制备方法
CN106565527A (zh) * 2016-11-02 2017-04-19 北京万全德众医药生物技术有限公司 一种酒石酸阿福特罗甲酰胺中间体的制备方法
CN107673957B (zh) * 2017-10-13 2020-10-23 河北工业大学 一种酸碱双功能离子液体催化低碳醛羟醛自缩合反应的方法
CN109627173A (zh) * 2019-01-19 2019-04-16 西南石油大学 一种氢转移选择性还原腈类制备仲胺的方法
CN112574055B (zh) * 2019-09-30 2024-07-09 天津天药药业股份有限公司 福莫特罗及其药用盐的制备方法及应用
CN113717060B (zh) * 2021-09-03 2024-03-15 成都新恒创药业有限公司 一种去甲肾上腺素及其重酒石酸盐的合成方法
CN115873909B (zh) * 2022-12-06 2023-08-11 天津法莫西生物医药科技有限公司 一种阿福特罗手性中间体的制备方法

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3994974A (en) 1972-02-05 1976-11-30 Yamanouchi Pharmaceutical Co., Ltd. α-Aminomethylbenzyl alcohol derivatives
JP3167705B2 (ja) * 1990-05-21 2001-05-21 広栄化学工業株式会社 ３―（ｎ―ベンジル―ｎ―アルコキシカルボニルアルキルアミノ）プロピオン酸エステルの製法
DE69417012T2 (de) * 1993-11-04 1999-10-07 Abbott Laboratories, Abbott Park Cyclobutan-derivate als inhibitoren der squalen-synthetase und der protein-farnesyltransferase
SE9404080L (sv) 1993-12-28 1995-06-29 Ciba Geigy Ag Förfarande för framställning av en optiskt ren enantiomer av formoterol
DK0938467T3 (da) * 1996-11-11 2002-10-07 Sepracor Inc Fremgangsmåde til fremstilling af optisk rene isomerer af formoterol
US6040344A (en) * 1996-11-11 2000-03-21 Sepracor Inc. Formoterol process
US5965622A (en) 1998-06-23 1999-10-12 Sepracor Inc. Desformoterol and process for its preparation
JP2000239237A (ja) * 1999-02-19 2000-09-05 Yamanouchi Pharmaceut Co Ltd 光学活性化合物の結晶及びその製法
JP2002255910A (ja) * 2001-02-27 2002-09-11 Nippon Kayaku Co Ltd １，１ービス（３−アミノー４ーヒドロキシフェニル）シクロアルカン類の製造方法
GB0118238D0 (en) * 2001-07-26 2001-09-19 Smithkline Beecham Plc Medicaments
GB2380996A (en) 2001-09-19 2003-04-23 Novartis Ag Hydroxy-nitrobenzene derivatives useful in the preparation of formoterol
WO2004099132A2 (en) * 2003-05-05 2004-11-18 Ranbaxy Laboratories Limited Process for the preparation of trans-isomers of diphenylazetidinone derivatives
GB0407908D0 (en) 2004-04-07 2004-05-12 Univ York Ionic liquids
JP4924034B2 (ja) 2004-05-24 2012-04-25 和光純薬工業株式会社 イオン性液体担持クラウン化合物
WO2008035380A2 (en) 2006-09-19 2008-03-27 Natco Pharma Limited An improved process for the preparation of high purity formoterol and its pharmaceutically acceptable salts
ES2539947T3 (es) 2008-06-02 2015-07-07 Cipla Limited Procedimiento para la síntesis de arformoterol

Also Published As

Publication number Publication date
EP2285770A1 (en) 2011-02-23
EP2285770B1 (en) 2015-05-20
JP2015063529A (ja) 2015-04-09
WO2009147383A1 (en) 2009-12-10
CA2724882A1 (en) 2009-12-10
NZ589497A (en) 2012-09-28
ZA201008222B (en) 2011-07-27
US9029421B2 (en) 2015-05-12
JP2011523658A (ja) 2011-08-18
US20110166237A1 (en) 2011-07-07
AU2009253877A1 (en) 2009-12-10
AU2009253877B2 (en) 2013-09-12
ES2539947T3 (es) 2015-07-07
US20150210629A1 (en) 2015-07-30

Similar Documents

Publication Publication Date Title
EP2285770B1 (en) Process for the synthesis of arformoterol
EP1915335B1 (en) Process for the preparation of cinacalcet base
US6268533B1 (en) Formoterol process
JPH0931033A (ja) 医薬有効物質としての６− ジメチルアミノメチル− １− フエニル− シクロヘキサン化合物
JP2001503772A (ja) フォルモテロールの光学的に純粋な異性体の製造方法
JP5901534B2 (ja) タペンタドールおよびその中間体を調製するための新しい方法
US8222454B2 (en) Process for preparing optical pure milnacipran and its pharmaceutically accepted salts
US20110313199A1 (en) processes for preparing substantially pure arformoterol and its intermediates
CA2335154C (en) Desformoterol and process for its preparation
WO2014005546A1 (zh) 他喷他多的制备方法及用于制备他喷他多的化合物
US8552219B2 (en) Process for preparing L-phenyl-3-dimethylaminopropane derivative
TW200815388A (en) Chromane and chromene derivatives and uses thereof
US6410787B2 (en) Process to prepare 2-aminoindan derivatives
CN114853660A (zh) 一种吲哚啉酮取代的环己二烯酮肟类化合物及其合成方法
CN102548955A (zh) 用于制备西那卡塞特的方法
WO2003104186A1 (ja) 光学活性β−アミノアルコールの製造法
WO2011050499A1 (zh) 盐酸西那卡塞的合成方法
CN105732309A (zh) 一种盐酸达泊西汀关键中间体的手性制备方法
CN102838493B (zh) 一种3-[(1r,2r)-3-(二甲胺基)-1-乙基-2-甲基丙基]苯酚的合成方法
AU748508B2 (en) Formoterol polymorphs
CN116693409A (zh) 一种(2s)-[4-(3-氟苄氧基)苄胺基]丙酸甲酯的制备方法
WO2013075679A1 (en) A method of producing cinacalcet

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20101229

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20140123

Comment text: Request for Examination of Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20150713

Patent event code: PE09021S01D

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

Patent event code: PE07011S01D

Comment text: Decision to Grant Registration

Patent event date: 20160215

NORF Unpaid initial registration fee
PC1904 Unpaid initial registration fee